Salmon company to inject fish with antibiotics ahead of expected marine heat wave
With Tasmania's salmon industry bracing for marine heatwave conditions this summer, one company is about to begin injecting fish with an antibacterial drug — with its preferred antibiotic option still off the table after the permit to use was revoked.
Tasmanian seafood company Tassal will begin injecting salmon in a pen with the antibiotic oxytetracycline (OTC) in response to an expected marine heat wave. The industry has been struggling with mass fish deaths during the past two summers due to the bacteria Piscirickettsia salmonis, which thrives in warmer waters. The federal regulator, APVMA, is currently assessing the industry's request for a florfenicol permit, which was suspended after concerns over residues affecting non-target species.
Tassal plans to inject up to 10 kilograms of OTC into diseased fish in Tasmania's south, using a new practice of treating individual fish directly at sea. This approach is expected to be more targeted and use less antibiotic compared to medicated feed. The industry has previously used florfenicol, but it was suspended due to safety concerns.
Dr. John Whittington, CEO of Salmon Tasmania, anticipates a marine heatwave and emphasized the industry's efforts to breed and vaccinate fish for resilience. However, he acknowledged the potential impact on wild fisheries like rock lobster and abalone and pledged to work constructively with them. Environmentalists, including Greens MP Vica Bayley, argue that treating diseased fish with antibiotics is not a sustainable solution for the environment or consumers.
Written by urgent.news from ABC News AU's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.